financetom
Business
financetom
/
Business
/
--Street Color: CME Group, S&P Global Exploring Sale of Post-Trade Joint Venture, Bloomberg Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Street Color: CME Group, S&P Global Exploring Sale of Post-Trade Joint Venture, Bloomberg Says
Aug 22, 2024 10:15 PM

11:42 AM EDT, 08/22/2024 (MT Newswires) --

Price: 209.17, Change: -0.23, Percent Change: -0.11

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Turtle Beach Adopts Poison Pill
Turtle Beach Adopts Poison Pill
Jun 9, 2025
10:57 AM EDT, 06/09/2025 (MT Newswires) -- Turtle Beach ( TBCH ) said Monday its board has adopted a limited-duration stockholder rights plan to protect against actions of third parties that the board deems are not in the best interests of the company and its shareholders. The rights under the plan would generally become exercisable once a person or group...
Village Farms International Regains Nasdaq Compliance
Village Farms International Regains Nasdaq Compliance
Jun 9, 2025
10:58 AM EDT, 06/09/2025 (MT Newswires) -- Village Farms International ( VFF ) said Monday that it was notified by Nasdaq that it has regained compliance with the minimum bid price requirement. Nasdaq determined that the matter is now closed, Village Farms ( VFF ) said. Shares of the company were up 2.5% in recent trading. Price: 1.22, Change: +0.03,...
Metsera's Phase 1 Trial of MET-233i Shows Weight Reduction With no Severe Adverse Events
Metsera's Phase 1 Trial of MET-233i Shows Weight Reduction With no Severe Adverse Events
Jun 9, 2025
10:54 AM EDT, 06/09/2025 (MT Newswires) -- Metsera ( MTSR ) said Monday its phase 1 trial of weight loss GLP-1 receptor candidate MET-233i showed an 8.4% mean placebo-subtracted weight loss on day 36 at a 1.2-milligram dosage. The trial of 80 participants with overweight or obesity without type 2 diabetes was designed to assess the pharmacokinetics, efficacy, and safety...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved